血清补体成分3、补体成分4和补体成分1q水平预测老年女性原发性闭角型青光眼患者进行性视野缺损
这项前瞻性队列研究纳入308例原发性闭角型青光眼患者,每6个月随访至少2年。在≥60岁女性亚组中,基线C3(HR=0.98,p<0.001)、C4(HR=0.96,p=0.01)和C1q(HR=0.99,p=0.003)水平较低与视野进展风险较高相关;男性和<60岁女性亚组无统计学意义。
要点
- 123例(39.94%)患者出现青光眼性视野进展。
- 仅≥60岁女性中,进展组C3、C4、C1q血清水平显著低于非进展组(p<0.05)。
- ≥60岁女性中,基线C3、C4、C1q较低与视野进展风险较高相关。
核心结论
- 仅在老年女性原发性闭角型青光眼患者中,基线C3、C4和C1q水平降低与视野缺损进展风险较高显著相关。
研究设计与样本
- 前瞻性队列研究,共纳入308例原发性闭角型青光眼患者,每6个月随访一次(至少2年),进行临床检查和视野测试,并按性别及年龄(<60岁和≥60岁)分层。
主要发现
- 123例(39.94%)患者出现青光眼性视野进展。
- 在≥60岁女性亚组中,进展组血清C3、C4和C1q水平显著低于非进展组(p<0.05)。
- 在≥60岁女性患者中,基线C3较低(HR=0.98,p<0.001)、C4较低(HR=0.96,p=0.01)和C1q较低(HR=0.99,p=0.003)与视野进展风险较高相关。
- 在≥60岁女性患者中,C3水平较低者视野缺损进展速率显著更高(p<0.05),C4较低和C1q较低者情况类似。
- 在≥60岁女性患者中,广义相加模型显示基线C3(p<0.001)、C4(p<0.001)和C1q(p<0.001)水平与视野进展风险呈负相关。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
AIM: To evaluate the association between serum levels of complement component (C) 3, C4 and C1q and visual field (VF) loss in patients with primary angle closure glaucoma (PACG). METHODS: In this prospective cohort study, a total of 308 patients with PACG were included. The patients were followed up every 6 months (at least 2 years), with clinical examination and VF testing. Based on their sex and age, the subjects were stratified into male and female subgroups, and by age at <60 and ≥60 years per subgroup. RESULTS: One hundred twenty-three (39.94%) patients showed glaucoma VF progression. The serum levels of C3, C4 and C1q were significantly lower (p<0.05) in the progression group compared with the non-progression group in the ≥60 years female subgroup. In female patients with age ≥60 years, (1) lower levels of baseline C3 (HR=0.98, p<0.001), C4 (HR=0.96, p=0.01) and C1q levels (HR=0.99, p=0.003) were associated with a greater risk of VF progression; (2) patients with lower C3 levels had significantly (p<0.05) higher rates of VF loss progression, similar to those with lower C4 and lower C1q levels; and (3) the generalised additive model revealed a negative correlation between baseline C3 (p<0.001), C4 (p<0.001) and C1q (p<0.001) levels with the risk of VF progression. No statistical significance was observed in the male (<60 and ≥60 years) and female (<60 years) subgroups. CONCLUSION: Decreased C3, C4 and C1q levels at baseline were significantly associated with a greater risk of VF loss progression only in older women with PACG.
引用
- Li S, Qiu Y, Yu J, et al. Serum complement component 3, complement component 4 and complement component 1q levels predict progressive visual field loss in older women with primary angle closure glaucoma. Br J Ophthalmol. 2022. PMID: 35017157. doi:10.1136/bjophthalmol-2021-320541
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。